Recorded Chinese product: 洛伐他汀片洛伐他汀片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

洛伐他汀是一种在国家药监局注册认定的药品。该药品含有洛伐他汀-66e890c0等成分。

该药品关联的活性成分包括:洛伐他汀Luofa Tating。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:永信药品工业(昆山)有限公司Chinese legal name: 永信药品工业(昆山有限公司)。

您可以探索含有相同成分的其他药品:洛伐他汀-66e890c0成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 洛伐他汀片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 洛伐他汀Luofa Tating.

Manufacturers recorded for this product: 永信药品工业(昆山)有限公司Chinese legal name: 永信药品工业(昆山有限公司).

Explore other medicines containing the same ingredient: 洛伐他汀 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 洛伐他汀片Recorded Chinese product: 洛伐他汀片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 20mg20 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 永信药品工业(昆山)有限公司Chinese legal name: 永信药品工业(昆山有限公司)

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20058917

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20058917

Manufacturer

Chinese legal name: 永信药品工业(昆山)有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20058917

生产企业

永信药品工业(昆山)有限公司(国产)

适应症

本品用于治疗高胆固醇血症和混合型高脂血症。

用法用量

本品成人常用量 口服:10~20mg(0.5―1片),每日一次,晚餐时服用。剂量可按需要调整,但最大剂量不超过每天80mg(4片)。

不良反应

1.本品最常见的不良反应为胃肠道不适、腹泻、胀气,其他还有头痛、皮疹、头晕、视觉模糊和味觉障碍。|2.偶可引起血氨基转移酶可逆性升高,因此需监测肝功能。|3.少见的不良反应有阳萎、失眠。|4.罕见的不良反应有肌炎、肌痛、横纹肌溶解,表现为肌肉疼痛、乏力、发烧,并伴有血肌酸磷酸激酶升高、肌红蛋白尿等,横纹肌溶解可导致肾功能衰竭,但较罕见。本品与免疫抑制剂、叶酸衍生物、烟酸、吉非罗齐、红霉素等合用可增加肌病发生的危险。|5.有报道发生过肝炎、胰腺炎及过敏反应如血管神经性水肿。

禁忌

1.对洛伐他汀过敏的患者禁用。|2.对其他HMG-CoA还原酶抑制剂过敏者慎用。|3..有活动性肝病或不明原因血氨基转移酶持续升高的患者禁用。

注意事项

1.用药期间应定期检查血胆固醇和血肌酸磷酸激酶。应用本品时血氨基转移酶可能增高,有肝病史者服用本品还应定期监测肝功能试验。|2.在本品治疗过程中如发生血氨基转移酶增高达正常高限的3倍,或血肌酸磷酸激酶显著增高或有肌炎、胰腺炎表现时,应停用本品。|3.应用本品时如有低血压、严重急性感染、创伤、代谢紊乱等情况,须注意可能出现的继发于肌溶解后的肾功能衰竭。|4.肾功能不全时,本品剂量应减少。|5.本品宜与饮食共进,以利吸收。|6.饮食疗法始终是治疗高血脂的首要方法,加上锻炼和减轻体重等方式,都将优于任何形式的药物治疗。

贮藏

遮光、密闭保存。

规格

20mg

证据Evidence

  • 批准文号: 国药准字H20058917
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.